Literature DB >> 19018038

Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall.

Godfrey S Getz1, Catherine A Reardon.   

Abstract

Apoprotein E (apoE) is synthesized by a number of tissues including the liver, brain, adipose tissue, and artery wall. The majority of apoE is found in the plasma associated with specific lipoprotein subclasses and is derived primarily from the liver. However the fact that apoE expression is sustained in nonhepatic tissues suggests that the local production must have some unique functional attribute. ApoE is involved in many steps in lipid and lipoprotein homeostasis, for the triglyceride-rich lipoproteins and for HDL. ApoE is also important for lipid homeostasis in the brain, artery wall, and adipose tissue through its synthesis by glial cells, adipocytes, and macrophages. In addition, nonlipid related functions have also been attributed to apoE, including effects on immune response and inflammation, oxidation, and smooth muscle proliferation and migration. Some of these effects have been shown to be dependent upon different domains of the protein, different concentrations, and lipidation state. Thus, this multifunctional protein impacts normal and pathophysiology at multiple levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19018038      PMCID: PMC2674757          DOI: 10.1194/jlr.R800058-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  49 in total

Review 1.  Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis.

Authors:  Joerg Heeren; Ulrike Beisiegel; Thomas Grewal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-12-22       Impact factor: 8.311

2.  Apolipoprotein-mediated pathways of lipid antigen presentation.

Authors:  Peter van den Elzen; Salil Garg; Luis León; Manfred Brigl; Elizabeth A Leadbetter; Jenny E Gumperz; Chris C Dascher; Tan-Yun Cheng; Frank M Sacks; Petr A Illarionov; Gurdyal S Besra; Sally C Kent; D Branch Moody; Michael B Brenner
Journal:  Nature       Date:  2005-10-06       Impact factor: 49.962

3.  Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.

Authors:  Robert L Raffai; Samuel M Loeb; Karl H Weisgraber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-12-09       Impact factor: 8.311

4.  Distinct cellular loci for the ABCA1-dependent and ABCA1-independent lipid efflux mediated by endogenous apolipoprotein E expression.

Authors:  Zhi H Huang; Michael L Fitzgerald; Theodore Mazzone
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-10-27       Impact factor: 8.311

5.  Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins.

Authors:  Yue Zhao; Fayanne E Thorngate; Karl H Weisgraber; David L Williams; John S Parks
Journal:  Biochemistry       Date:  2005-01-25       Impact factor: 3.162

6.  Apolipoprotein E suppresses the type I inflammatory response in vivo.

Authors:  Kamilah Ali; Melissa Middleton; Ellen Puré; Daniel J Rader
Journal:  Circ Res       Date:  2005-09-22       Impact factor: 17.367

Review 7.  The key role of apolipoprotein E in atherosclerosis.

Authors:  Kirsty Greenow; Nigel J Pearce; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2005-04-13       Impact factor: 4.599

8.  HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway.

Authors:  Fumihiko Matsuura; Nan Wang; Wengen Chen; Xian-Cheng Jiang; Alan R Tall
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

9.  Putting cholesterol in its place: apoE and reverse cholesterol transport.

Authors:  Robert W Mahley; Yadong Huang; Karl H Weisgraber
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

10.  The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity.

Authors:  Thomas Pham; Ahmer Kodvawala; David Y Hui
Journal:  Biochemistry       Date:  2005-05-24       Impact factor: 3.162

View more
  96 in total

1.  Fluorescence analysis of the lipid binding-induced conformational change of apolipoprotein E4.

Authors:  Chiharu Mizuguchi; Mami Hata; Padmaja Dhanasekaran; Margaret Nickel; Michael C Phillips; Sissel Lund-Katz; Hiroyuki Saito
Journal:  Biochemistry       Date:  2012-07-03       Impact factor: 3.162

Review 2.  Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review.

Authors:  C Roger White; David W Garber; G M Anantharamaiah
Journal:  J Lipid Res       Date:  2014-08-25       Impact factor: 5.922

3.  Animal models of cardiovascular disease as test beds of bioengineered vascular grafts.

Authors:  Sindhu Row; Daniel D Swartz; Stelios T Andreadis
Journal:  Drug Discov Today Dis Models       Date:  2018-06-18

4.  Influence of 6 genetic variants on the efficacy of statins in patients with dyslipidemia.

Authors:  Ruth Cano-Corres; Beatriz Candás-Estébanez; Ariadna Padró-Miquel; Marta Fanlo-Maresma; Xavier Pintó; Pedro Alía-Ramos
Journal:  J Clin Lab Anal       Date:  2018-05-07       Impact factor: 2.352

Review 5.  Low-Density Lipoprotein Receptor-Related Proteins in Skeletal Development and Disease.

Authors:  Tao Yang; Bart O Williams
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

Review 6.  Mechanisms that regulate macrophage burden in atherosclerosis.

Authors:  Gwendalyn J Randolph
Journal:  Circ Res       Date:  2014-05-23       Impact factor: 17.367

Review 7.  The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

Authors:  Hong-liang Zhang; Jiang Wu; Jie Zhu
Journal:  J Biomed Biotechnol       Date:  2010-02-16

8.  apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.

Authors:  Panagiotis Fotakis; Alexander Vezeridis; Ioannis Dafnis; Angeliki Chroni; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2014-04-28       Impact factor: 5.922

9.  Allele-dependent thermodynamic and structural perturbations in ApoE variants associated with the correction of dyslipidemia and formation of spherical ApoE-containing HDL particles.

Authors:  Dimitra Georgiadou; Angeliki Chroni; Konstantinos Drosatos; Kyriakos E Kypreos; Vassilis I Zannis; Efstratios Stratikos
Journal:  Atherosclerosis       Date:  2012-11-23       Impact factor: 5.162

Review 10.  The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Hong-Liang Zhang; Jiang Wu; Jie Zhu
Journal:  Clin Dev Immunol       Date:  2010-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.